Abdominal Obesity Metabolic Syndrome  >>  pioglitazone  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00639457: Exercise and Pioglitazone for HIV-Metabolic Syndromes

Completed
N/A
44
US
Pioglitazone, Actos, Exercise training, Physical activity
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
HIV Infections, Type 2 Diabetes, Obesity, HIV, AIDS, Cardiovascular Disease, Lipodystrophy
12/08
12/09
WU197, NCT00656851: Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome

Completed
N/A
24
US
Pioglitazone, Actos, Exercise Training, Physical activity, Aerobic exercise, Weight lifting exercise
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
HIV Infections, Cardiovascular Disease, Insulin Resistance, HIV Lipodystrophy, The Metabolic Syndrome
08/09
08/10
ADT, NCT00743327: Androgen Deprivation Therapy Study

Terminated
N/A
1
US
Pioglitazone, Actos
National Institute on Aging (NIA)
Hypogonadism, Metabolic Syndrome, Diabetes, Inflammation
08/12
08/12
NCT00470262: Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation

Completed
N/A
27
US
Fenofibrate 145mg PO QD, Tricor, Pioglitazone 45 mg PO QD, Actos
VA Office of Research and Development
Metabolic Syndrome X, Prediabetic State
12/12
06/14
NCT02002975: Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"

Completed
N/A
18223
NA
Pioglitazone, ACTOS
Takeda
Type 2 Diabetes Mellitus
06/13
06/13

Download Options